Current Issue Contents

provides a monthly update on managing musculoskeletal disorders in daily practice. Crossing traditional specialty lines, JMM pulls together information you need from rheumatology, orthopedics, sports medicine, cardiology, neurology and related specialties, as well as from primary care medicine.CURRENT ISSUE: VOL 29/NO 4   MAY 2012             

 

provides a monthly update on managing musculoskeletal disorders in daily practice. Crossing traditional specialty lines, JMM pulls together information you need from rheumatology, orthopedics, sports medicine, cardiology, neurology and related specialties, as well as from primary care medicine.

CURRENT ISSUE: VOL 29/NO 4   MAY 2012             

ARTICLE ARCHIVE

 

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
A panel of 5 experts on iron deficiency anemia
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Related Content
Habit-Based Interventions Increase Treatment Adherence in Gout

Habit-Based Interventions Increase Treatment Adherence in Gout

Lana Pine
July 26th 2024
Article
Health Consequences of Climate Change with Janelle Bludorn, PA-C, MS

Health Consequences of Climate Change with Janelle Bludorn, PA-C, MS

Kevin Kunzmann
July 22nd 2024
Podcast
New Data Highlights Nemolizumab with TCS Versus Calcineurin Inhibitors for Eczema

New Data Highlights Nemolizumab with TCS Versus Calcineurin Inhibitors for Eczema

Tim Smith
July 25th 2024
Article
Innovations in GERD: What Vonoprazan (Voquezna) May Offer Over PPIs, with Adelina Hung, MD

Innovations in GERD: What Vonoprazan (Voquezna) May Offer Over PPIs, with Adelina Hung, MD

Abigail Brooks, MA
July 18th 2024
Podcast
Jessica Golbus, MD | Credit: Michigan Medicine

Periodic Text Messages Can Improve Daily Activity During Cardiac Rehab

Patrick Campbell
July 25th 2024
Article
Arthritis Disease Severity Peaks in Spring and Fall, According to PROs

Arthritis Disease Severity Peaks in Spring and Fall, According to PROs

Lana Pine
July 25th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.